J. Papke

发表

Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study

M. Stauch, A. Hinke, H. Hindenburg, 2012, BMC Cancer.

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

M. Stauch, J. Trojan, R. Hofheinz, 2020, International journal of cancer.

Supportiv oder palliativ

J. Papke, 2013 .

High Efficacy and Low Toxicity of Weekly Docetaxel Given as First-Line Treatment for Metastatic Breast Cancer

M. Stauch, V. Heinemann, C. Jackisch, 2005, Oncology.

Places of Death from Cancer in a Rural Location

R. Koch, J. Papke, 2007, Oncology Research and Treatment.

Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients

M. Gompels, L. Alsina, E. Drewe, 2017, Pharmacology research & perspectives.

A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and Clarithromycin

M. Vieth, M. Stolte, W. Schneider-Brachert, 2003, Helicobacter.

Places of cancer death in Germany.

J. Papke, 2004, Journal of pain and symptom management.

Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study

M. Stauch, A. Hinke, H. Hindenburg, 2012, BMC Cancer.

[Recurrent tetany as the first symptom of late manifesting celiac disease].

J. Papke, E. Raude, 1998, Medizinische Klinik.

Current Situation of Outpatient Palliative Care in Germany

J. Papke, Ute Rosenbaum, 2012 .